![](/images/graphics-bg.png)
To Treat or Not to Treat : The Role of Adjuvant Radioiodine Therapy in Thyroid Cancer Patients
Joint Authors
Quiros, Roderick M.
Carballo, Marilee
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-11-01
Country of Publication
Egypt
No. of Pages
11
Main Subjects
Abstract EN
Radioactive iodine (RAI) is used in treatment of patients with differentiated papillary and follicular thyroid cancer.
It is typically used after thyroidectomy, both as a means of imaging to detect residual thyroid tissue or metastatic disease, as well as a means of treatment by ablation if such tissue is found.
In this paper, we discuss the indications for and the mechanisms of RAI in the treatment of patients with thyroid cancer.
We discuss the attendant risks and benefits that come with its use, as well as techniques used to optimize its effectiveness as an imaging tool and a therapeutic modality.
American Psychological Association (APA)
Carballo, Marilee& Quiros, Roderick M.. 2012. To Treat or Not to Treat : The Role of Adjuvant Radioiodine Therapy in Thyroid Cancer Patients. Journal of Oncology،Vol. 2012, no. 2012, pp.1-11.
https://search.emarefa.net/detail/BIM-492153
Modern Language Association (MLA)
Carballo, Marilee& Quiros, Roderick M.. To Treat or Not to Treat : The Role of Adjuvant Radioiodine Therapy in Thyroid Cancer Patients. Journal of Oncology No. 2012 (2012), pp.1-11.
https://search.emarefa.net/detail/BIM-492153
American Medical Association (AMA)
Carballo, Marilee& Quiros, Roderick M.. To Treat or Not to Treat : The Role of Adjuvant Radioiodine Therapy in Thyroid Cancer Patients. Journal of Oncology. 2012. Vol. 2012, no. 2012, pp.1-11.
https://search.emarefa.net/detail/BIM-492153
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-492153